613 related articles for article (PubMed ID: 19808309)
1. Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005.
Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Miller LW; Deng M; Naka Y; Mancini D
Circ Heart Fail; 2009 Jan; 2(1):3-10. PubMed ID: 19808309
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
[TBL] [Abstract][Full Text] [Related]
3. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
[TBL] [Abstract][Full Text] [Related]
5. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
6. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era.
Miller LW; Nelson KE; Bostic RR; Tong K; Slaughter MS; Long JW
J Heart Lung Transplant; 2006 Jul; 25(7):778-84. PubMed ID: 16818120
[TBL] [Abstract][Full Text] [Related]
7. Implantable left ventricular assist devices: new hope for patients with end-stage heart failure.
Milano CA; Lodge AJ; Blue LJ; Smith PK; Felker GM; Hernandez AF; Rosenberg PB; Rogers JG
N C Med J; 2006; 67(2):110-5. PubMed ID: 16752713
[TBL] [Abstract][Full Text] [Related]
8. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
[TBL] [Abstract][Full Text] [Related]
9. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
Radovancevic B; Vrtovec B; de Kort E; Radovancevic R; Gregoric ID; Frazier OH
J Heart Lung Transplant; 2007 Aug; 26(8):815-8. PubMed ID: 17692785
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation.
Grady KL; Meyer PM; Dressler D; Mattea A; Chillcott S; Loo A; White-Williams C; Todd B; Ormaza S; Kaan A; Costanzo MR; Piccione W
Ann Thorac Surg; 2004 Apr; 77(4):1321-7. PubMed ID: 15063260
[TBL] [Abstract][Full Text] [Related]
11. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
[TBL] [Abstract][Full Text] [Related]
12. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure.
Dang NC; Topkara VK; Mercando M; Kay J; Kruger KH; Aboodi MS; Oz MC; Naka Y
J Heart Lung Transplant; 2006 Jan; 25(1):1-6. PubMed ID: 16399523
[TBL] [Abstract][Full Text] [Related]
13. Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients.
Teuteberg JJ; Ewald GA; Adamson RM; Lietz K; Miller LW; Tatooles AJ; Kormos RL; Sundareswaran KS; Farrar DJ; Rogers JG
J Am Coll Cardiol; 2012 Jul; 60(1):44-51. PubMed ID: 22541834
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device.
Gregoric ID; Bruckner BA; Jacob L; Kar B; Cohn WE; La Francesca S; Frazier OH
Ann Thorac Surg; 2008 May; 85(5):1646-9. PubMed ID: 18442556
[TBL] [Abstract][Full Text] [Related]
15. Preoperative risk factors for mortality after biventricular assist device implantation.
Zahr F; Ootaki Y; Starling RC; Smedira NG; Yamani M; Thuita L; Fukamachi K
J Card Fail; 2008 Dec; 14(10):844-9. PubMed ID: 19041048
[TBL] [Abstract][Full Text] [Related]
16. Clinical strategies and outcomes in advanced heart failure patients older than 70 years of age receiving the HeartMate II left ventricular assist device: a community hospital experience.
Adamson RM; Stahovich M; Chillcott S; Baradarian S; Chammas J; Jaski B; Hoagland P; Dembitsky W
J Am Coll Cardiol; 2011 Jun; 57(25):2487-95. PubMed ID: 21679851
[TBL] [Abstract][Full Text] [Related]
17. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy.
Park SJ; Milano CA; Tatooles AJ; Rogers JG; Adamson RM; Steidley DE; Ewald GA; Sundareswaran KS; Farrar DJ; Slaughter MS;
Circ Heart Fail; 2012 Mar; 5(2):241-8. PubMed ID: 22282104
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular assist devices as destination therapy: a new look at survival.
Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy.
Topilsky Y; Pereira NL; Shah DK; Boilson B; Schirger JA; Kushwaha SS; Joyce LD; Park SJ
Circ Heart Fail; 2011 May; 4(3):266-75. PubMed ID: 21303989
[TBL] [Abstract][Full Text] [Related]
20. Does the type of ventricular assisted device influence survival, infection, and rejection rates following heart transplantation?
Shuhaiber J; Hur K; Gibbons R
J Card Surg; 2009; 24(3):250-5. PubMed ID: 19438776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
